203 related articles for article (PubMed ID: 23933765)
1. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.
Teschner D; Distler E; Wehler D; Frey M; Marandiuc D; Langeveld K; Theobald M; Thomas S; Herr W
Bone Marrow Transplant; 2014 Jan; 49(1):138-44. PubMed ID: 23933765
[TBL] [Abstract][Full Text] [Related]
2. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
[TBL] [Abstract][Full Text] [Related]
3. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.
Mangare C; Tischer-Zimmermann S; Riese SB; Dragon AC; Prinz I; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897843
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
[TBL] [Abstract][Full Text] [Related]
5. Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
Bachar-Lustig E; Lask A; Eidelstein Y; Or-Geva N; Gidron-Budovsky R; Nathansohn-Levy B; Eyrich M; Liu WH; Dang G; Miranda KC; Ramirez A; Kaur I; Rezvani K; Shpall E; Champlin RE; Nagler A; Shimoni A; Barnees-Kagan S; Reisner Y
Transplant Cell Ther; 2024 Jan; 30(1):71.e1-71.e13. PubMed ID: 37890590
[TBL] [Abstract][Full Text] [Related]
6. Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.
Verfuerth S; Sousa PS; Beloki L; Murray M; Peters MD; O'Neill AT; Mackinnon S; Lowdell MW; Chakraverty R; Samuel ER
Bone Marrow Transplant; 2015 Oct; 50(10):1358-64. PubMed ID: 26076125
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic selective donor-derived CD4
Varlet P; Rogeau S; Trauet J; Demaret J; Labalette M
Curr Res Transl Med; 2019 Feb; 67(1):1-7. PubMed ID: 30665880
[TBL] [Abstract][Full Text] [Related]
8. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
Wehler TC; Nonn M; Brandt B; Britten CM; Gröne M; Todorova M; Link I; Khan SA; Meyer RG; Huber C; Hartwig UF; Herr W
Blood; 2007 Jan; 109(1):365-73. PubMed ID: 16931626
[TBL] [Abstract][Full Text] [Related]
9. Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.
Mangare C; Tischer-Zimmermann S; Bonifacius A; Riese SB; Dragon AC; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Transfus Med Hemother; 2022 Feb; 49(1):30-43. PubMed ID: 35221866
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
Shook DR; Triplett BM; Eldridge PW; Kang G; Srinivasan A; Leung W
Pediatr Blood Cancer; 2015 Apr; 62(4):666-73. PubMed ID: 25559618
[TBL] [Abstract][Full Text] [Related]
11. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples.
Powell DJ; Parker LL; Rosenberg SA
J Immunother; 2005; 28(4):403-11. PubMed ID: 16000960
[TBL] [Abstract][Full Text] [Related]
12. Depletion of CD45RA
Bremm M; Krastel T; Cappel C; Zimmermann O; Pfeffermann LM; Katzki V; Bonig H; Schäfer R; Rettinger E; Merker M; Bremm S; Schaefer K; Klingebiel T; Soerensen J; Bader P; Huenecke S
J Immunol Methods; 2021 May; 492():112960. PubMed ID: 33417916
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
14. Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).
Smetak M; Kimmel B; Birkmann J; Schaefer-Eckart K; Einsele H; Wilhelm M; Kunzmann V
Bone Marrow Transplant; 2008 Apr; 41(7):643-50. PubMed ID: 18037935
[TBL] [Abstract][Full Text] [Related]
15. Depletion of alloreactive donor T cells using immunomagnetic cell selection.
Fehse B; Goldmann M; Frerk O; Bulduk M; Zander AR
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S39-42. PubMed ID: 10933186
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.
Meyer RG; Britten CM; Wehler D; Bender K; Hess G; Konur A; Hartwig UF; Wehler TC; Ullmann AJ; Gentilini C; Uharek L; Huber C; Kolbe K; Herr W
Blood; 2007 Jan; 109(1):374-82. PubMed ID: 16940425
[TBL] [Abstract][Full Text] [Related]
17. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation.
Marktel S; Magnani Z; Ciceri F; Cazzaniga S; Riddell SR; Traversari C; Bordignon C; Bonini C
Blood; 2003 Feb; 101(4):1290-8. PubMed ID: 12393508
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
Pittet MJ; Zippelius A; Speiser DE; Assenmacher M; Guillaume P; Valmori D; Liénard D; Lejeune F; Cerottini JC; Romero P
J Immunol; 2001 Jun; 166(12):7634-40. PubMed ID: 11390521
[TBL] [Abstract][Full Text] [Related]
19. Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.
Bleakley M; Heimfeld S; Jones LA; Turtle C; Krause D; Riddell SR; Shlomchik W
Biol Blood Marrow Transplant; 2014 May; 20(5):705-16. PubMed ID: 24525279
[TBL] [Abstract][Full Text] [Related]
20. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
